NERV

Minerva Neurosciences, Inc. NERV

NERV
Minerva Neurosciences, Inc. RVPH
Reviva Pharmaceuticals Holdings, Inc. TCRX
TScan Therapeutics, Inc. TNYA
Tenaya Therapeutics, Inc. CRVS
Corvus Pharmaceuticals, Inc. KALA
KALA BIO, Inc. MTVA
MetaVia Inc. ATXI
Avenue Therapeutics, Inc. ARDX
Ardelyx, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NERV RVPH TCRX TNYA CRVS KALA MTVA ATXI ARDX
6M 62.07 % -3.68 % 78.23 % 326.05 % 132.55 % -57.57 % -32.57 % 173.02 % 10.65 %
YTD 2.17 % -67.67 % -28.48 % 47.89 % 27.62 % -81.45 % -53.66 % -63.21 % -3.61 %
1Y -8.91 % -47.16 % -60.18 % 24.26 % 2.06 % -72.34 % -61.35 % -65.02 % -17.61 %
3Y -82.18 % -80.60 % -21.91 % -20.75 % 661.54 % -87.93 % -61.35 % -99.61 % 255.04 %
5Y -91.04 % -93.97 % -78.95 % -86.32 % 63.44 % -99.65 % -61.35 % -99.98 % 252.50 %
10Y -93.92 % -93.31 % -78.95 % -86.32 % -51.37 % -99.85 % -61.35 % -99.99 % -1.89 %
From the beginning -95.14 % -93.31 % -78.95 % -86.32 % -51.37 % -99.85 % -61.35 % -99.99 % 39.80 %

Dividend